Preprints 1. Bakouny Z, Sadagopan A, Ravi P, Metaferia NY, Li J, AbuHammad S, Tang S, Denize T, Garner ER, Gao X, Braun DA, Hirsch L, Steinharter JA, Bouchard G, Walton E, West D, Labaki C, Dudani S, Gan C-L, Sethunath V, Carvalho FL, Imamovic A, Ricker C, Vokes NI, Nyman J, Park J, Hirsch MS, Haq R, Lee G-SM, McGregor BA, Chang SL, Feldman AS, Wu CJ, McDermott DF, Heng DYC, Signoretti S, Allen EMV*, Choueiri TK*, Viswanathan SR* (2021). Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma. bioRxiv. Cold Spring Harbor Laboratory; 2021 Apr 15;2021.04.14.439908. https://doi.org/10.1101/2021.04.14.439908. [Link to published version]
2. Tang S, Metaferia NY, Nogueira MF, Gelbard MK, Abou Alaiwi S, Seo J-H, Hwang JH, Strathdee CA, Baca SC, Li J, AbuHammad S, Zhang X, Doench JG, Hahn WC, Takeda DY, Freedman ML, Choi PS*, Viswanathan SR* (2020) Genome-scale genetic screening identifies PRMT1 as a critical vulnerability in castration-resistant prostate cancer. bioRxiv 2020.06.17.156034. https://doi.org/10.1101/2020.06.17.156034. [Link to published version]
3. Zhou, M.*, Ko, M.*, Hoge, A.C., Luu, K., Liu, Y., Russell, M.L., Hannon, W.W., Zhang, Z., Carrot-Zhang, J., Beroukhim, R., Van Allen, E., Choudhury, A.D., Nelson, P.S., Freedman, M.L., Taplin, M.-E., Meyerson, M., Viswanathan, S.R.*, Ha, G.*, 2022. Patterns of Structural Variation Define Prostate Cancer Across Disease States. bioRxiv 2022.01.09.475586. https://doi.org/10.1101/2022.01.09.475586 [Link to published version]
4. Achom M*, Sadagopan A*, Bao C*, McBride F, Xu Q, Konda P, Tourdot RW, Li J, Nakhoul M, Gallant D, Ahmed UA, O’Toole J, Freeman D, Lee GSM, Hecht J, Kauffman E, Einstein DJ, Choueiri TK, Zhang CZ**, Viswanathan SR**. A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma [Internet]. bioRxiv; 2023 [cited 2023 Aug 9]. p. 2023.08.04.552029. Available from: https://www.biorxiv.org/content/10.1101/2023.08.04.552029v1
